文献速递肝胆胰外科围术期管理与 ERAS

10岁以下儿童暴发性肝衰竭的辅助性部分原位肝移植:多中心经验

Auxiliary Partial Orthotopic Liver Transplantation in Children Under 10 Years Old With Fulminant Hepatic Failure: A Multicenter Experience.
PubMed 文献 · Ann Surg · 2026-08-31

结论认为该术式安全有效,长期生存优异且自体肝再生率高。

要点

  • 10岁以下暴发性肝衰竭患儿接受APOLT后25年总生存率达97.6%。
  • 95.0%患儿确认自体肝再生并成功撤除免疫抑制,最终80%脱离免疫抑制。
  • 围术期无90天内死亡,主要并发症包括肝动脉血栓7.1%、胆道狭窄7.1%等。

核心结论

  • APOLT是10岁以下暴发性肝衰竭患儿安全有效的治疗方法,长期生存优异且自体肝再生率高。

主要发现

  • 中位年龄3.2岁(四分位距1.69至5.89),男性占59.5%。
  • 病因包括特发性19例、自身免疫性肝炎8例、腺病毒7例,83.3%使用左外侧段移植物。
  • 90天内无围术期死亡,围术期并发症包括肝动脉血栓7.1%、门静脉血栓4.8%、胆道狭窄7.1%、胆漏2.4%。
  • 中位随访11.1年(四分位距6.74至15.7),25年总生存率97.6%。
  • 95.0%(38/40)确认自体肝再生并成功撤除免疫抑制,4例(9.5%)需再移植,最终80%脱离免疫抑制,意向性治疗分析中76.2%脱离免疫抑制。

临床怎么用

  • 对于10岁以下暴发性肝衰竭患儿,APOLT可作为安全有效的术式选择,有望在自体肝再生后撤除终身免疫抑制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure (FHF) allows potential withdrawal of lifelong immunosuppression (ISP) following native liver regeneration, which may be advantageous in young children with high regenerative capacity. Despite these potential benefits, APOLT has been rarely used, and long-term outcomes in children under 10 years remain unclear. This study aimed to evaluate perioperative safety, long-term outcomes, and native liver regeneration rates in children under 10 years undergoing APOLT for FHF at major centers in the UK and the USA. MATERIALS AND METHODS: We conducted a multicenter international retrospective study using data from King's College Hospital, Columbia University, and the University of Miami. Children under 10 years with FHF who underwent APOLT between 1996 and 2025 were included. RESULTS: Forty-two patients were analyzed. Median age was 3.2 years (interquartile range, 1.69 to 5.89), and 59.5% were males. Etiologies included idiopathic (n = 19), autoimmune hepatitis (n = 8), and adenovirus (n = 7). Left lateral segment grafts were used in 83.3%. No perioperative mortality occurred within 90 days. Perioperative morbidity included hepatic artery thrombosis (7.1%), portal vein thrombosis (4.8%), biliary strictures (7.1%), and bile leaks (2.4%). Median follow-up was 11.1 years (interquartile range, 6.74 to 15.7), with a 25-year overall survival of 97.6%. Native liver regeneration was confirmed in 95.0% (38/40) with successful withdrawal from ISP. Four patients (9.5%) required retransplantation; in 2 of them, APOLT was repeated. Finally, 40 patients underwent APOLT, and 80% are off ISP and 76.2% in the intention-to-treat analysis. CONCLUSION: APOLT is a safe and effective treatment for patients under 10 years old with FHF, providing excellent long-term survival and a high rate of native liver regeneration.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Fujiwara S, Assia-Zamora S, Cortes-Cerisuelo M, et al. Auxiliary Partial Orthotopic Liver Transplantation in Children Under 10 Years Old With Fulminant Hepatic Failure: A Multicenter Experience. Ann Surg. 2026. PMID: 42669855. doi:10.1097/SLA.0000000000007198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。